Trials / Completed
CompletedNCT01714063
Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- Philips Respironics · Industry
- Sex
- All
- Age
- 5 Years – 8 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to determine ex vivo the amount of fluticasone deposited onto a filter (delivered dose) interposed between the OptiChamber Diamond Valved Holding Chamber (VHC) mouthpiece and the subject's mouth during coordinated and uncoordinated actuation/inhalation maneuver.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pressurized Metered-Dose Inhaler | Pressurized Metered-Dose Inhaler |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2012-10-25
- Last updated
- 2019-04-24
- Results posted
- 2019-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01714063. Inclusion in this directory is not an endorsement.